Trial Profile
A randomised placebo controlled study to evaluate the effects of zoledronic acid in reducing the progression of erosions in psoriatic arthritis.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms ZAPA
- 29 Jun 2016 New trial record